142 related articles for article (PubMed ID: 32142018)
1. Screening for Opioid and Stimulant Exposure In Utero Through Targeted and Untargeted Metabolomics Analysis of Umbilical Cords.
Mamillapalli SS; Smith-Joyner A; Forbes L; McIntyre K; Poppenfuse S; Rushing B; Strom C; Danell AS; May L; Kuehn D; Kew K; Ravisankar S
Ther Drug Monit; 2020 Oct; 42(5):787-794. PubMed ID: 32142018
[TBL] [Abstract][Full Text] [Related]
2. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy.
Concheiro M; Lendoiro E; de Castro A; Gónzalez-Colmenero E; Concheiro-Guisan A; Peñas-Silva P; Macias-Cortiña M; Cruz-Landeira A; López-Rivadulla M
Drug Test Anal; 2017 Jun; 9(6):898-904. PubMed ID: 27595432
[TBL] [Abstract][Full Text] [Related]
3. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.
de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
Ther Drug Monit; 2011 Aug; 33(4):443-52. PubMed ID: 21743375
[TBL] [Abstract][Full Text] [Related]
4. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection.
Concheiro M; González-Colmenero E; Lendoiro E; Concheiro-Guisán A; de Castro A; Cruz-Landeira A; López-Rivadulla M
Ther Drug Monit; 2013 Aug; 35(4):502-9. PubMed ID: 23851907
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of opiates, methadone, amphetamines, cocaine, and metabolites in human placenta and umbilical cord by LC-MS/MS.
de Castro A; Díaz A; Piñeiro B; Lendoiro E; Cruz A; López-Rivadulla M; Concheiro M
Anal Bioanal Chem; 2013 May; 405(12):4295-305. PubMed ID: 23397092
[TBL] [Abstract][Full Text] [Related]
6. Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy.
González-Colmenero E; Concheiro-Guisán A; Lorenzo-Martínez M; Concheiro M; Lendoiro E; de-Castro-Ríos A; Cañizo-Vázquez D; Martínez-Reglero C; Fernández-Lorenzo JR
J Addict Dis; 2021; 39(2):175-182. PubMed ID: 33043834
[TBL] [Abstract][Full Text] [Related]
7. Detection of neonatal drug exposure using umbilical cord tissue and liquid chromatography time-of-flight mass spectrometry.
Marin SJ; Metcalf A; Krasowski MD; Linert BS; Clark CJ; Strathmann FG; McMillin GA
Ther Drug Monit; 2014 Feb; 36(1):119-24. PubMed ID: 24061447
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC-MS-MS.
Feng J; Wang L; Dai I; Harmon T; Bernert JT
J Anal Toxicol; 2007 Sep; 31(7):359-68. PubMed ID: 17725883
[TBL] [Abstract][Full Text] [Related]
9. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure.
Colby JM
Clin Biochem; 2017 Sep; 50(13-14):784-790. PubMed ID: 28288850
[TBL] [Abstract][Full Text] [Related]
10. Detection of in utero cannabis exposure by umbilical cord analysis.
Kim J; de Castro A; Lendoiro E; Cruz-Landeira A; López-Rivadulla M; Concheiro M
Drug Test Anal; 2018 Apr; 10(4):636-643. PubMed ID: 28948698
[TBL] [Abstract][Full Text] [Related]
11. Broad-spectrum drug screening of meconium by liquid chromatography with tandem mass spectrometry and time-of-flight mass spectrometry.
Ristimaa J; Gergov M; Pelander A; Halmesmäki E; Ojanperä I
Anal Bioanal Chem; 2010 Sep; 398(2):925-35. PubMed ID: 20617307
[TBL] [Abstract][Full Text] [Related]
12. Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: A retrospective study at an academic medical center.
Palmer KL; Wood KE; Krasowski MD
Clin Biochem; 2017 Apr; 50(6):255-261. PubMed ID: 27890824
[TBL] [Abstract][Full Text] [Related]
13. Detection of opioids in umbilical cord lysates: an antibody-based rapid screening approach.
Knight SJ; Smith AD; Wright TE; Collier AC
Toxicol Mech Methods; 2019 Jan; 29(1):35-42. PubMed ID: 30064290
[TBL] [Abstract][Full Text] [Related]
14. Development of a liquid chromatography-tandem mass spectrometry method to address the increased utilization of umbilical cord in the assessment of in utero drug exposure.
Haglock-Adler CJ; McMillin GA; Strathmann FG
Clin Biochem; 2016 Sep; 49(13-14):1092-5. PubMed ID: 27131494
[TBL] [Abstract][Full Text] [Related]
15. Method performance and clinical workflow outcomes associated with meconium and umbilical cord toxicology testing.
Labardee RM; Swartzwelder JR; Gebhardt KE; Pardi JA; Dawsey AC; Brent Dixon R; Cotten SW
Clin Biochem; 2017 Dec; 50(18):1093-1097. PubMed ID: 28941590
[TBL] [Abstract][Full Text] [Related]
16. Are point-of-care urine drug testing devices suitable for antenatal drug screening? A study verifying the Alere® Drug Screen Test Cup for the detection of six classes of drug in a pregnant population.
Dale RC; Ford LT; Street C
Ann Clin Biochem; 2021 May; 58(3):166-173. PubMed ID: 33435699
[TBL] [Abstract][Full Text] [Related]
17. Nicotine and metabolites in paired umbilical cord tissue and meconium specimens.
Marin SJ; Christensen RD; Baer VL; Clark CJ; McMillin GA
Ther Drug Monit; 2011 Feb; 33(1):80-5. PubMed ID: 21192312
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Neonatal Co-Exposure to Gabapentin and Commonly Abused Drugs Observed in Umbilical Cord Tissue.
Okoye NC; McMillin GA
J Anal Toxicol; 2021 May; 45(5):506-512. PubMed ID: 32860706
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
Manchikanti L; Malla Y; Wargo BW; Fellows B
Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
[TBL] [Abstract][Full Text] [Related]
20. Umbilical Cord Collection and Drug Testing to Estimate Prenatal Substance Exposure in Utah.
Smid MC; Allshouse AA; McMillin GA; Nunez K; Cavin T; Worden J; Buchi K; Muniyappa B; Varner MW; Cochran G; Metz TD
Obstet Gynecol; 2022 Aug; 140(2):153-162. PubMed ID: 35852263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
